Duke University Medical Center; University of North Carolina at Chapel Hill
- Consultant: Agency for Toxic Solvent Disease Registry/Centers for Disease Control (ATSDR/CDC ); Abbott Laboratories; Biovail; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Johnson & Johnson; Novartis Pharmaceutical Corporation; Organon Pharmaceuticals USA Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Shire Pharmaceuticals Inc.; Solvay S.A; Wyeth; sanofi-aventis
- Grant Support: Abbott Laboratories; AstraZeneca LP; Biovail; Bristol-Myers Squibb; Burroughs Wellcome Fund; Cephalon, Inc.; Ciba-Geigy; CoMentis; Corcept; Eisai; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Johnson & Johnson; Lundbeck; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; MediciNova; Merck & Co., Inc.; National Institute of Mental Health (NIMH); Neurochem; New River Pharmaceuticals; Novartis Pharmaceutical Corporation; Organon Pharmaceuticals USA Inc.; Parke Davis; Pfizer Inc; Pharmacia; Saegis; Sandoz; Schwabe/Ingenix; Shire Pharmaceuticals Inc.; SmithKline Beecham; Solvay S.A; Synaptic Pharmaceutical Incorporated; Takeda Pharmaceuticals North America, Inc. ; UCB S.A.; Upjohn; Vela; Wyeth; sanofi-aventis
- Research Support: Abbott Laboratories; AstraZeneca LP; Biovail; Bristol-Myers Squibb; Burroughs Wellcome Fund; Cephalon, Inc.; Ciba-Geigy; CoMentis; Corcept; Eisai; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Johnson & Johnson; Lundbeck; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; MediciNova; Merck & Co., Inc.; National Institute of Mental Health (NIMH); Neurochem; New River Pharmaceuticals; Novartis Pharmaceutical Corporation; Organon Pharmaceuticals USA Inc.; Parke Davis; Pfizer Inc; Pharmacia; Saegis; Sandoz; Schwabe/Ingenix; Shire Pharmaceuticals Inc.; SmithKline Beecham; Solvay S.A; Synaptic Pharmaceutical Incorporated; Takeda Pharmaceuticals North America, Inc. ; UCB S.A.; Upjohn; Vela; Wyeth; sanofi-aventis
- Speakers Bureau: Abbott Laboratories; AstraZeneca LP; Biovail; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Organon Pharmaceuticals USA Inc.; Pfizer Inc; Shire Pharmaceuticals Inc.; Solvay S.A; Wyeth; sanofi-aventis
- Stockholder: Bristol-Myers Squibb; Merck & Co., Inc.; Pfizer Inc